IMMUNO-COV™ – The Test for Antibodies that Block SARS-CoV-2 Infection Read More

February 25, 2021

Rochester’s Vyriad developing oral COVID-19 vaccine

Vyriad, a Rochester biotech firm founded by Mayo Clinic researchers, is developing an oral vaccine for the coronavirus that could be used as a booster in the months after the initial wave of vaccinations.

Media Inquiries

For inquiries, please contact mediarelations@vyriad.com